Director, HEOR Strategy, US Access Evidence Strategy and Execution is accountable for development and execution of Immunology Inflation Reduction Act (IRA) value & evidence strategy and frameworks, capabilities to support drug price “negotiation” program (DPNP) efforts between AbbVie and CMS for the Neuroscience portfolio. He or she will report into Director, HEOR Strategy, Therapeutic Toxins TA Lead.